(USD) | Dec 2023 | Q/Q |
---|---|---|
Revenue | 3.7B | +4% |
Operating Income | 331.2MM | +16% |
Operating Expenses | 3.4B | +3% |
Net Income | 216.4MM | +30% |
Compensation | 1.8B | +1% |
Amortization | 145.5MM | +6% |
Interest Expense | 53.6MM | +0% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Universal Health's (UHS) first-quarter results benefit from improved patient days in both segments. However, higher expenses partially offset the positives.
Robust Performance Driven by Strong Acute and Behavioral Health Care Services
While the top- and bottom-line numbers for Universal Health Services (UHS) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Universal Health Services (UHS) delivered earnings and revenue surprises of 17.83% and 1.97%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Universal Health Services, Inc. (NYSE: UHS) announced today that its reported net income attributable to UHS was $261.8 million, or $3.82 per diluted share, during the first quarter of 2024, as compared to $163.1 million, or $2.28 per diluted share, during the first quarter of 2023. Net revenues increased by 10.8% to $3.844 billion during the first quarter of 2024, as compared to $3.468 billion during the first quarter of 2023.
Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President and Chief Financial Officer will present at the following conferences:
Improved premiums resulting from membership growth, and higher patient admissions are expected to have driven the Q1 performance of HUM, MOH, UHS, EHC and CYH. An elevated operating expense level is likely to have dented growth prospects.
Evaluate the expected performance of Universal Health Services (UHS) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
What is good for hospitals and healthcare providers can be bad for health insurers. When hospitals are full of patients, insurers aren’t likely to do well. Investors had been betting that medical utilization would continue to stay elevated in the first quarter, supported by reports of strong hospital volumes early on this year and the fact that prior authorizations were waived as a result of the cyberattack on Change Healthcare, a major clearinghouse for medical claims.